China authorizes use of covid vaccines for children aged 3 to 17

China has authorized the emergency use of two covid-19 vaccines produced by Sinovac Biotech Ltd. and Sinopharm in people aged 3 to 17, as the country rushes to vaccinate its more than 1.4 billion inhabitants.

Both vaccines were given the green light after Extensive clinical trials have found them to be safe and able to stimulate a strong immune response in children and adolescents, Shao Yiming, a researcher at the China Center for Disease Control and Prevention, said Friday at a briefing in Beijing.

WHO supports Sinopharm vaccine and expands options for Covax

Officials they did not say when the vaccines would start.

Sinovac CEO Yin Weidong said earlier this month that Phase I and II research involved several hundred participants and showed the company’s vaccine to be as safe and effective for children as it is for them. adults.

Covid vaccinations had covered around 620 million people in China as of June 10Cui Gang, a member of the National Health Commission’s Office of Disease Prevention and Control, said as the world’s most populous country advances in mass vaccination despite no plans to open its borders. China has been largely successful in curbing the spread of the virus, but in recent weeks it has grappled with an outbreak in southern Guangdong province.

WHO approved Sinovac vaccine for global use

China’s Fast-Track Vaccine Campaign comes as the United States pushes for new research to determine how the covid came about, and so find out, among other hypotheses, if it leaked from a laboratory in Wuhan city . Group of Seven leaders to call for new origins study commissioned by World Health Organization (WHO) this weekend, Bloomberg reported.

Mi Feng, a spokesperson for the NHC, dismissed the theory, saying the result of the report of the investigation into the origin of the virus carried out jointly by experts from China and the WHO showed that it is little likely SARS-CoV-2 leaked from a lab.